Apg Asset Management N.V. Novavax Inc Transaction History

Apg Asset Management N.V.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$36.28 - $75.29 $116,096 - $240,928	-3,200 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$69.73 - $142.9 $348,650 - $714,500	-5,000 Reduced 60.98%	3,200 $212,000
Q4 2021 Feb 11, 2022	BUY	$134.56 - $217.97 $430,592 - $697,504	3,200 Added 64.0%	8,200 $1.03 Million
Q3 2021 Nov 15, 2021	SELL	$177.8 - $270.58 $266,700 - $405,870	-1,500 Reduced 23.08%	5,000 $894,000
Q2 2021 Aug 13, 2021	BUY	$121.0 - $257.67 $786,500 - $1.67 Million	6,500 New	6,500 $1.16 Million

284

83.2M

5.43M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $1.04B
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

Stay updated on Apg Asset Management N.V. with notifications on news.